208 related articles for article (PubMed ID: 2410510)
1. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
Tamerius JD; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1985 Sep; 135(3):2015-9. PubMed ID: 2410510
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
3. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
4. Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen.
Kanayama Y; Kurata Y; McMillan R; Tamerius JD; Negoro N; Curd JG
J Immunol Methods; 1986 Apr; 88(1):33-6. PubMed ID: 2420896
[TBL] [Abstract][Full Text] [Related]
5. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
6. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
8. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
9. Three rat monoclonal antibodies to human C3.
Lachmann PJ; Oldroyd RG; Milstein C; Wright BW
Immunology; 1980 Nov; 41(3):503-15. PubMed ID: 6161872
[TBL] [Abstract][Full Text] [Related]
10. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
Lachmann PJ; Pangburn MK; Oldroyd RG
J Exp Med; 1982 Jul; 156(1):205-16. PubMed ID: 6177820
[TBL] [Abstract][Full Text] [Related]
11. Characterization of three monoclonal antibodies against C3 with selective specificities.
Iida K; Mitomo K; Fujita T; Tamura N
Immunology; 1987 Nov; 62(3):413-7. PubMed ID: 2444528
[TBL] [Abstract][Full Text] [Related]
12. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
13. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
[TBL] [Abstract][Full Text] [Related]
14. Determination of complement breakdown fragments C3d and its subfragments in health and disease.
Tamotsu M; Arai K; Fujita S; Hosotsubo K; Hayashi C; Miyai K; Miyano A; Kawanaka K; Takenaka M; Shimizu A
Diagn Immunol; 1984; 2(2):116-21. PubMed ID: 6333963
[TBL] [Abstract][Full Text] [Related]
15. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
Lachmann PJ; Voak D; Oldroyd RG; Downie DM; Bevan PC
Vox Sang; 1983; 45(5):367-72. PubMed ID: 6605620
[TBL] [Abstract][Full Text] [Related]
16. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
Krettli AU; Pontes de Carvalho LC
Clin Exp Immunol; 1985 Nov; 62(2):270-7. PubMed ID: 3910312
[TBL] [Abstract][Full Text] [Related]
17. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
18. Generation of low m.w., C3-bearing immunoglobulin in human serum.
Jacobs RJ; Reichlin M
J Immunol; 1983 Jun; 130(6):2775-81. PubMed ID: 6602181
[TBL] [Abstract][Full Text] [Related]
19. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
20. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with factor I deficiency and with autoimmune diseases.
Møller Rasmussen J; Jepsen HH; Teisner B; Holmskov-Nielsen U; Rasmussen GG; Svehag SE
Vox Sang; 1989; 56(4):262-9. PubMed ID: 2474900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]